Please use this identifier to cite or link to this item: http://hdl.handle.net/2381/37058
Title: Phenotypically adapted Mycobacterium tuberculosis populations from sputum are tolerant to first line drugs
Authors: Turapov, O.
O'Connor, B. D.
Sarybaeva, A. A.
Williams, C.
Patel, H.
Kadyrov, A. S.
Sarybaev, A. S.
Woltmann, G.
Barer, M. R.
Mukamolova, Galina V.
First Published: 16-Feb-2016
Publisher: American Society for Microbiology
Citation: Antimicrobial Agents and Chemotherapy, 2016, 60 (4), 2476-2483.
Abstract: Tuberculous sputum contains multiple Mycobacterium tuberculosis (Mtb) populations with different requirements for isolation in vitro. These include cells forming colonies on solid media (platable Mtb), cells requiring standard liquid medium for growth (non-platable Mtb), and cells requiring supplementation of liquid medium with culture supernatant for growth (SN-dependent Mtb). Here we describe protocols for the cryopreservation and direct assessment of antimicrobial tolerance of these Mtb populations within sputum. Our results show that first line drugs achieved only modest cidal effects on all three populations over 7 days (1-2.5xlog10 reductions) and SN-dependent Mtb were more tolerant to streptomycin and isoniazid compared to platable and non-platable Mtb. Susceptibility of platable Mtb to bactericidal drugs was significantly increased after passage in vitro, thus tolerance observed in the sputum populations was likely associated with mycobacterial adaptation to the host environment at some time prior to expectoration. Our findings support the use of a simple ex vivo system for testing drug efficacies against mycobacteria phenotypically adapted during tuberculosis infection.
DOI Link: 10.1128/AAC.01380-15
ISSN: 0066-4804
eISSN: 1098-6596
Links: http://aac.asm.org/content/60/4/2476
http://hdl.handle.net/2381/37058
Version: Publisher Version
Status: Peer-reviewed
Type: Journal Article
Rights: Copyright © 2016 Turapov et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 3.0 Unported license ( http://creativecommons.org/licenses/by/3.0/ ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Appears in Collections:Published Articles, Dept. of Infection, Immunity and Inflammation

Files in This Item:
File Description SizeFormat 
Antimicrob. Agents Chemother.-2016-Turapov-2476-83.pdfPublished (publisher PDF)1.04 MBAdobe PDFView/Open


Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.